Home About Us Contact Us

 

Table of Content - Volume 10 Issue 2 - May 2018


 

Metabolic syndrome in HIV/AIDS in Manipur

 

Hidangmayum Dwijaraj Singh1, Thiyam Brojendro Singh2*, Rothangpui3, Konsam Biona Devi4, Abhik Dev5, Banteilang Challam6

 

1Assistant Professor, 2Associate Professor, 4Senior Resident, 5,6Post Graduate, Department of Medicine, Regional Institute of Medical Sciences (RIMS), Imphal.

3Associate Professor of Medicine, Jawaharlal Nehru Institute of medical sciences(JNIMS), Imphal.

Email: bionanew@gmail.com

 

REFERENCES

  1. Eva K, Panagiota P, Gregory K, George C. Metabolic syndrome: definitions and controversies. BMC Medicine 2011; 9:48.
  2. Fauci AS, Lane HC. Human Immunodeficiency Virus Disease : AIDS and Related Disorders. In: Longo DL, Fausi AS, Kasper DS, Hauser SL, Jameson JL and Loscalzo J, editors. Harrison’s Principle of Internal Medicine.18th ed. New York: McGraw Hill; 2012.p. 1506-87.
  3. Kristin M, Edgar TO, Jessica G, Shao T, Warren S, William P, et al. Metabolic Syndrome in HIV – Infected Patients. Clin Infect Dis 2007; 44: 726 -34.
  4. Carr A, Samaras K, Burton S, Matthew L, Judith F, Donald J, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and Insulin resistance in patients receiving HIV protease inhibitions. AIDS 1998; 12: 51-8.
  5. Sullivan AK, Nelson MR, Feher MD, Gazzard BG. Marked hyperlipidaemia on ritonavir therapy. AIDS 1998; 12: 51–8.
  6. Jerico C, Knobel H, Montero M, Ana G, Gimeno JL, Pere S, et al. Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors. Diabetes Care 2005; 28: 132–7.
  7. Palella F, Wang Z, Chu H, Riddler S, Vischer B, Bobs A, et al. Correlates and prevalence of the metabolic syndrome over time in the Multicenter AIDS Cohort Study (MACS). In: Program and abstracts of the 3rd IAS Conference on HIV Pathogenesis and Treatment Rio de Janeiro, Brazil 2005[abstract TuPe2.2B18].
  8. Idiculla J, Rabindra GD, D’Souza J, Singh G, Furruqh S. Diabetes mellitus, insulin resistance, and metabolic syndrome in HIV-positive patients in south India. Int J Gen Med 2011; 4: 43-78.
  9. Tadewos A, Addis Z, Ambachew H, Banerjee S. Prevalence of dyslipidemia among HIV-infected patients using first-line highly active antiretroviral therapy in Southern Ethiopia: a cross-sectional comparative group study. AIDS Res Ther 2012; 9: 31.
  10. Villamar MF, Albuja AC, Salas NIC. Metabolic syndrome among HIV-infected outpatients from a hospital in Quito, Equador:a cross-sectional study. Rev Panam Infectol 2011; 13(2): 12-18.
  11. Kalra S, Kalra B, Agrawal N, Unnikrishnan AG. Understanding diabetes in patients with HIV/AIDS. Diabetol Metab Syndr 2011; 3: 2.
  12. Mondy K, Overton ET, Grubb J, tong S, Seyfied W, Powderly W, et al. Metabolic Syndrome in HIV-Infected Patients from an Urban, Midwestern US Outpatient Population. Clin Infect Dis 2007 Mar 1; 55(5): 726-34.
  13. Mauricio F V, Ana CA, Nelson ICS. Metabolic Syndrome among HIV-infected out patients from a hospital in Quito, Ecuador :a cross sectional study. Rev Panam infectol 2011; 13(2): 12-18.
  14. Mangili A, Jacobson DL, Gerrior J, Polak JF, Gorbach SL, Wanke CA: Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV. Clin Infect Dis 2007; 44: 1368-74.
  15. Worm SW, Friis-MøllerN, BruyandM, Rickenbach M, Peter R, Philip A et al. “High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome. AIDS 2010; 24: 427-35.
Journal Menu MIJOMED Medpulse Manuscript Submission Subscription Aim & Scope Peer Review Process Publication Ethics & Malpractice Statement Open Access Statement Plagiarism Policy Editorial Board Indexing Current Issue Publication Charges Archives Authors Information Copyright & Licensing Privacy Statement Contact Us